| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 78 | 2023 | 1242 | 15.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 28 | 2023 | 310 | 8.400 |
Why?
|
| Hematopoiesis | 26 | 2023 | 560 | 6.010 |
Why?
|
| DNA Methylation | 31 | 2023 | 2669 | 4.980 |
Why?
|
| Cell Differentiation | 37 | 2023 | 4078 | 2.650 |
Why?
|
| Epigenesis, Genetic | 20 | 2023 | 1399 | 2.630 |
Why?
|
| Bone Marrow Cells | 21 | 2015 | 943 | 2.410 |
Why?
|
| Stem Cells | 16 | 2024 | 1213 | 2.360 |
Why?
|
| Cell Separation | 15 | 2013 | 612 | 2.260 |
Why?
|
| Mice | 105 | 2023 | 34495 | 1.920 |
Why?
|
| Adult Stem Cells | 4 | 2015 | 73 | 1.880 |
Why?
|
| Protein Phosphatase 2C | 4 | 2022 | 75 | 1.880 |
Why?
|
| Gene Editing | 5 | 2019 | 216 | 1.850 |
Why?
|
| Animals | 125 | 2023 | 59536 | 1.790 |
Why?
|
| Cellular Senescence | 8 | 2024 | 382 | 1.760 |
Why?
|
| Cell Lineage | 16 | 2018 | 668 | 1.570 |
Why?
|
| Hematologic Neoplasms | 8 | 2022 | 1870 | 1.550 |
Why?
|
| Gene Expression Regulation | 16 | 2020 | 4053 | 1.550 |
Why?
|
| Flow Cytometry | 15 | 2013 | 3033 | 1.510 |
Why?
|
| DNA Modification Methylases | 3 | 2022 | 172 | 1.440 |
Why?
|
| Mutation | 24 | 2024 | 15179 | 1.420 |
Why?
|
| Mice, Inbred C57BL | 41 | 2019 | 6942 | 1.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 6 | 2015 | 622 | 1.310 |
Why?
|
| Bone Marrow | 10 | 2020 | 2358 | 1.230 |
Why?
|
| CRISPR-Cas Systems | 4 | 2018 | 323 | 1.130 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2020 | 2488 | 1.130 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2020 | 2359 | 1.120 |
Why?
|
| Leukemia, Myeloid, Acute | 11 | 2022 | 6915 | 1.120 |
Why?
|
| Cell Proliferation | 21 | 2020 | 7226 | 1.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 7 | 2019 | 560 | 1.080 |
Why?
|
| Bone Marrow Transplantation | 15 | 2015 | 1581 | 1.080 |
Why?
|
| Histones | 9 | 2022 | 1466 | 1.070 |
Why?
|
| Neoplasm Proteins | 7 | 2019 | 3230 | 1.010 |
Why?
|
| GTP-Binding Proteins | 3 | 2011 | 321 | 0.990 |
Why?
|
| Nuclear Proteins | 6 | 2020 | 3343 | 0.980 |
Why?
|
| Homeodomain Proteins | 5 | 2021 | 1143 | 0.930 |
Why?
|
| Mice, Knockout | 21 | 2020 | 5710 | 0.910 |
Why?
|
| Embryonic Stem Cells | 6 | 2013 | 301 | 0.890 |
Why?
|
| Gene Expression Profiling | 14 | 2023 | 5159 | 0.890 |
Why?
|
| Promoter Regions, Genetic | 6 | 2019 | 3101 | 0.870 |
Why?
|
| Aging | 7 | 2023 | 1582 | 0.860 |
Why?
|
| Side-Population Cells | 2 | 2013 | 18 | 0.850 |
Why?
|
| Antigens, CD | 5 | 2011 | 1385 | 0.840 |
Why?
|
| Mosaicism | 1 | 2024 | 272 | 0.830 |
Why?
|
| Clonal Evolution | 3 | 2020 | 253 | 0.820 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2020 | 1498 | 0.810 |
Why?
|
| Genomic Imprinting | 2 | 2013 | 194 | 0.800 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2021 | 480 | 0.800 |
Why?
|
| Chromatin | 6 | 2020 | 942 | 0.790 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2022 | 108 | 0.780 |
Why?
|
| Benzimidazoles | 8 | 2011 | 428 | 0.780 |
Why?
|
| DNA-Binding Proteins | 8 | 2020 | 4821 | 0.770 |
Why?
|
| Clone Cells | 2 | 2020 | 555 | 0.770 |
Why?
|
| Leukocyte Common Antigens | 9 | 2016 | 188 | 0.760 |
Why?
|
| Fires | 1 | 2020 | 22 | 0.740 |
Why?
|
| DNA, Neoplasm | 2 | 2017 | 1910 | 0.730 |
Why?
|
| Environment | 1 | 2021 | 190 | 0.730 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 224 | 0.710 |
Why?
|
| RNA, Long Noncoding | 3 | 2020 | 598 | 0.680 |
Why?
|
| Cell Cycle | 8 | 2020 | 2084 | 0.680 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 242 | 0.650 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 47 | 0.650 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1032 | 0.620 |
Why?
|
| Cells, Cultured | 16 | 2018 | 5637 | 0.610 |
Why?
|
| Environmental Exposure | 1 | 2019 | 288 | 0.600 |
Why?
|
| Transgenes | 3 | 2008 | 557 | 0.590 |
Why?
|
| Leukemia | 4 | 2016 | 1635 | 0.580 |
Why?
|
| Humans | 79 | 2023 | 261506 | 0.570 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 70 | 0.570 |
Why?
|
| Dioxygenases | 5 | 2020 | 159 | 0.540 |
Why?
|
| Health | 1 | 2015 | 54 | 0.540 |
Why?
|
| Antigens, Ly | 4 | 2012 | 49 | 0.530 |
Why?
|
| Cesium Radioisotopes | 1 | 2015 | 39 | 0.530 |
Why?
|
| Tuberculosis | 3 | 2011 | 548 | 0.520 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 470 | 0.520 |
Why?
|
| Gene Regulatory Networks | 3 | 2015 | 677 | 0.520 |
Why?
|
| Myeloid Cells | 3 | 2012 | 269 | 0.510 |
Why?
|
| X-Rays | 1 | 2015 | 146 | 0.510 |
Why?
|
| CpG Islands | 6 | 2017 | 633 | 0.510 |
Why?
|
| Methyltransferases | 1 | 2016 | 148 | 0.510 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 338 | 0.510 |
Why?
|
| Muscle, Skeletal | 7 | 2023 | 1270 | 0.500 |
Why?
|
| Green Fluorescent Proteins | 5 | 2008 | 694 | 0.490 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 270 | 0.490 |
Why?
|
| HEK293 Cells | 6 | 2021 | 1489 | 0.490 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 220 | 0.480 |
Why?
|
| Inflammation | 3 | 2020 | 2522 | 0.480 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 1555 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2017 | 2291 | 0.450 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 159 | 0.450 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 107 | 0.450 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2011 | 2508 | 0.450 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2012 | 1 | 0.450 |
Why?
|
| Signal Transduction | 11 | 2019 | 11965 | 0.440 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2011 | 3639 | 0.430 |
Why?
|
| Immunity | 3 | 2011 | 342 | 0.430 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2012 | 49 | 0.430 |
Why?
|
| T-Lymphocytes | 4 | 2018 | 3869 | 0.430 |
Why?
|
| Carcinogenesis | 1 | 2018 | 1026 | 0.420 |
Why?
|
| Tetraspanin 28 | 1 | 2011 | 13 | 0.420 |
Why?
|
| Rejuvenation | 2 | 2022 | 72 | 0.410 |
Why?
|
| Homeostasis | 4 | 2011 | 950 | 0.410 |
Why?
|
| Chemokine CCL5 | 1 | 2012 | 71 | 0.410 |
Why?
|
| Alleles | 4 | 2011 | 2437 | 0.410 |
Why?
|
| Cell Culture Techniques | 5 | 2015 | 598 | 0.410 |
Why?
|
| Membrane Proteins | 6 | 2012 | 2819 | 0.400 |
Why?
|
| Ataxia | 1 | 2013 | 176 | 0.400 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 44 | 0.400 |
Why?
|
| Doxorubicin | 1 | 2018 | 3005 | 0.400 |
Why?
|
| Alchemy | 1 | 2011 | 3 | 0.400 |
Why?
|
| Pluripotent Stem Cells | 3 | 2013 | 123 | 0.400 |
Why?
|
| Cisplatin | 1 | 2018 | 2432 | 0.390 |
Why?
|
| Protein Isoforms | 3 | 2022 | 842 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 246 | 0.390 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 66 | 0.390 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2010 | 41 | 0.390 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 801 | 0.390 |
Why?
|
| Dermis | 1 | 2011 | 65 | 0.390 |
Why?
|
| Epigenomics | 3 | 2018 | 266 | 0.380 |
Why?
|
| Cell Division | 9 | 2011 | 2489 | 0.380 |
Why?
|
| Colony-Forming Units Assay | 7 | 2010 | 249 | 0.380 |
Why?
|
| Science | 1 | 2011 | 35 | 0.380 |
Why?
|
| Cell Line | 7 | 2020 | 5114 | 0.370 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2015 | 6550 | 0.360 |
Why?
|
| Fluorescent Dyes | 7 | 2011 | 459 | 0.360 |
Why?
|
| Doxycycline | 2 | 2008 | 178 | 0.360 |
Why?
|
| Autistic Disorder | 1 | 2013 | 319 | 0.360 |
Why?
|
| Intestine, Small | 1 | 2013 | 499 | 0.350 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2330 | 0.350 |
Why?
|
| Leukemia, Experimental | 2 | 2020 | 78 | 0.350 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 3552 | 0.350 |
Why?
|
| CCCTC-Binding Factor | 2 | 2020 | 33 | 0.340 |
Why?
|
| Lymphoma | 2 | 2023 | 1467 | 0.340 |
Why?
|
| Fibroblasts | 2 | 2019 | 1682 | 0.340 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 488 | 0.340 |
Why?
|
| Genome, Human | 2 | 2017 | 1869 | 0.330 |
Why?
|
| Stem Cell Transplantation | 7 | 2007 | 1360 | 0.330 |
Why?
|
| Transplantation Conditioning | 2 | 2015 | 2238 | 0.330 |
Why?
|
| Models, Animal | 1 | 2011 | 664 | 0.330 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 217 | 0.330 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 292 | 0.320 |
Why?
|
| Phenotype | 10 | 2012 | 6295 | 0.320 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2022 | 278 | 0.320 |
Why?
|
| Genes, Homeobox | 2 | 2019 | 147 | 0.320 |
Why?
|
| RNA Splicing | 2 | 2010 | 370 | 0.310 |
Why?
|
| Insulator Elements | 1 | 2007 | 7 | 0.310 |
Why?
|
| 5-Methylcytosine | 3 | 2018 | 56 | 0.310 |
Why?
|
| DNA Damage | 3 | 2020 | 1954 | 0.300 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 589 | 0.300 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 107 | 0.300 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 848 | 0.300 |
Why?
|
| DNA Repair | 4 | 2023 | 1872 | 0.300 |
Why?
|
| Cell Transplantation | 4 | 2010 | 85 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2020 | 5539 | 0.290 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 2979 | 0.290 |
Why?
|
| Lentivirus | 1 | 2007 | 169 | 0.290 |
Why?
|
| Organ Specificity | 3 | 2015 | 699 | 0.290 |
Why?
|
| Receptors, Cell Surface | 2 | 2007 | 862 | 0.290 |
Why?
|
| Computational Biology | 4 | 2021 | 1271 | 0.280 |
Why?
|
| Cytoplasm | 2 | 2019 | 652 | 0.280 |
Why?
|
| Regeneration | 5 | 2015 | 279 | 0.280 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 305 | 0.280 |
Why?
|
| Lysine | 2 | 2020 | 422 | 0.280 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 289 | 0.280 |
Why?
|
| Interferon-gamma | 1 | 2010 | 1144 | 0.270 |
Why?
|
| Transduction, Genetic | 2 | 2007 | 475 | 0.270 |
Why?
|
| Thy-1 Antigens | 1 | 2005 | 51 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8873 | 0.270 |
Why?
|
| Databases, Genetic | 2 | 2013 | 745 | 0.260 |
Why?
|
| Repressor Proteins | 3 | 2020 | 1664 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1491 | 0.260 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2020 | 291 | 0.260 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2020 | 467 | 0.260 |
Why?
|
| Embryo Research | 1 | 2005 | 10 | 0.260 |
Why?
|
| Hepatocytes | 2 | 2004 | 351 | 0.260 |
Why?
|
| Genetic Vectors | 2 | 2007 | 1694 | 0.260 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 4143 | 0.250 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 238 | 0.250 |
Why?
|
| Rett Syndrome | 2 | 2020 | 262 | 0.250 |
Why?
|
| Erythroid Precursor Cells | 2 | 2003 | 61 | 0.250 |
Why?
|
| NADH Dehydrogenase | 1 | 2004 | 15 | 0.240 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2004 | 116 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2054 | 0.240 |
Why?
|
| Neoplasms, Experimental | 2 | 2018 | 750 | 0.240 |
Why?
|
| Cell Count | 4 | 2010 | 508 | 0.240 |
Why?
|
| Muscle Cells | 1 | 2003 | 38 | 0.230 |
Why?
|
| Heterochromatin | 1 | 2023 | 83 | 0.230 |
Why?
|
| Thymocytes | 2 | 2021 | 18 | 0.230 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 129 | 0.230 |
Why?
|
| Mutation, Missense | 3 | 2021 | 1152 | 0.230 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1070 | 0.220 |
Why?
|
| Biomarkers | 6 | 2020 | 5047 | 0.220 |
Why?
|
| Software | 3 | 2017 | 1321 | 0.220 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 239 | 0.220 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 81 | 0.220 |
Why?
|
| Tumor Stem Cell Assay | 3 | 2020 | 231 | 0.220 |
Why?
|
| Swine, Miniature | 1 | 2002 | 67 | 0.220 |
Why?
|
| Transcription, Genetic | 6 | 2019 | 3154 | 0.220 |
Why?
|
| Cell Survival | 1 | 2009 | 3045 | 0.210 |
Why?
|
| Liver Regeneration | 1 | 2003 | 134 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 1084 | 0.210 |
Why?
|
| Physical Conditioning, Animal | 1 | 2023 | 112 | 0.210 |
Why?
|
| Gene Knockout Techniques | 3 | 2019 | 276 | 0.210 |
Why?
|
| Myelopoiesis | 2 | 2020 | 31 | 0.200 |
Why?
|
| Apoptosis | 6 | 2016 | 7591 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 7222 | 0.200 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 27 | 0.200 |
Why?
|
| Central Nervous System | 1 | 2004 | 436 | 0.200 |
Why?
|
| RNA, Messenger | 4 | 2015 | 6150 | 0.200 |
Why?
|
| Adipogenesis | 1 | 2022 | 105 | 0.200 |
Why?
|
| Neurons | 3 | 2019 | 2287 | 0.200 |
Why?
|
| Cell Movement | 2 | 2010 | 2466 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 435 | 0.200 |
Why?
|
| Discoidin Domain Receptors | 1 | 2020 | 9 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 3203 | 0.190 |
Why?
|
| Artifacts | 1 | 2004 | 532 | 0.190 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2020 | 11 | 0.190 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 6089 | 0.190 |
Why?
|
| Liver | 3 | 2010 | 2961 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2018 | 1442 | 0.190 |
Why?
|
| Hematopoietic System | 2 | 2010 | 26 | 0.190 |
Why?
|
| K562 Cells | 2 | 2020 | 338 | 0.190 |
Why?
|
| Genetic Techniques | 1 | 2021 | 130 | 0.190 |
Why?
|
| Smoke | 1 | 2020 | 60 | 0.180 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2020 | 118 | 0.180 |
Why?
|
| Monocytes | 1 | 2004 | 788 | 0.180 |
Why?
|
| Gene Silencing | 4 | 2019 | 837 | 0.180 |
Why?
|
| GABAergic Neurons | 1 | 2020 | 47 | 0.180 |
Why?
|
| Gene Frequency | 1 | 2003 | 1163 | 0.180 |
Why?
|
| Cytokines | 4 | 2019 | 2809 | 0.180 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 123 | 0.180 |
Why?
|
| Sequence Alignment | 3 | 2010 | 844 | 0.180 |
Why?
|
| Mycobacterium avium | 2 | 2010 | 22 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2019 | 72 | 0.170 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 538 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 132 | 0.170 |
Why?
|
| Hematologic Tests | 1 | 2019 | 82 | 0.170 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 10331 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2020 | 287 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4549 | 0.170 |
Why?
|
| Cell Nucleolus | 1 | 2019 | 89 | 0.170 |
Why?
|
| RNA Interference | 1 | 2003 | 1408 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3821 | 0.170 |
Why?
|
| Burkitt Lymphoma | 1 | 2021 | 335 | 0.170 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2020 | 245 | 0.160 |
Why?
|
| Interferon-alpha | 2 | 2015 | 889 | 0.160 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 4233 | 0.160 |
Why?
|
| Serine | 1 | 2020 | 388 | 0.160 |
Why?
|
| Transcription Factors | 4 | 2020 | 5270 | 0.160 |
Why?
|
| Cell Self Renewal | 2 | 2015 | 62 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 197 | 0.160 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 220 | 0.160 |
Why?
|
| Methylation | 2 | 2016 | 597 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2006 | 2086 | 0.160 |
Why?
|
| Tenericutes | 1 | 2017 | 2 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 1217 | 0.160 |
Why?
|
| Genomic Instability | 2 | 2019 | 519 | 0.160 |
Why?
|
| Models, Biological | 4 | 2014 | 3254 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2019 | 2074 | 0.160 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 430 | 0.150 |
Why?
|
| Microinjections | 1 | 2017 | 96 | 0.150 |
Why?
|
| Protein Domains | 1 | 2019 | 314 | 0.150 |
Why?
|
| DNA Primers | 2 | 2011 | 1399 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1073 | 0.150 |
Why?
|
| Adenoviridae | 1 | 2003 | 1459 | 0.150 |
Why?
|
| Karyopherins | 1 | 2018 | 136 | 0.150 |
Why?
|
| Sulfites | 1 | 2017 | 44 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 344 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 14551 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 461 | 0.150 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2016 | 16 | 0.150 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 14 | 0.150 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 931 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 566 | 0.140 |
Why?
|
| Hydrazines | 1 | 2018 | 208 | 0.140 |
Why?
|
| Cytosine | 2 | 2014 | 141 | 0.140 |
Why?
|
| Mice, Mutant Strains | 3 | 2013 | 634 | 0.140 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 189 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 2010 | 479 | 0.140 |
Why?
|
| Protein Transport | 1 | 2019 | 734 | 0.140 |
Why?
|
| Proteolysis | 1 | 2018 | 370 | 0.140 |
Why?
|
| Metabolomics | 1 | 2020 | 478 | 0.140 |
Why?
|
| Cell Fusion | 3 | 2005 | 80 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 905 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 1546 | 0.140 |
Why?
|
| Genetic Drift | 1 | 2015 | 30 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2011 | 271 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 854 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 755 | 0.140 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2016 | 52 | 0.140 |
Why?
|
| Lethal Dose 50 | 1 | 2015 | 32 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 14289 | 0.130 |
Why?
|
| Kinetics | 2 | 2011 | 2049 | 0.130 |
Why?
|
| Myocardium | 2 | 2016 | 1313 | 0.130 |
Why?
|
| Blood Cells | 1 | 2015 | 127 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2012 | 3536 | 0.130 |
Why?
|
| Selection, Genetic | 1 | 2015 | 189 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 673 | 0.130 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2014 | 35 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 2232 | 0.120 |
Why?
|
| Time Factors | 4 | 2016 | 12926 | 0.120 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2014 | 83 | 0.120 |
Why?
|
| Hydroxyurea | 1 | 2015 | 204 | 0.120 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 33 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 521 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 2216 | 0.120 |
Why?
|
| Adenosine | 1 | 2016 | 289 | 0.120 |
Why?
|
| Receptor, Notch1 | 2 | 2018 | 218 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 591 | 0.120 |
Why?
|
| Triazoles | 1 | 2018 | 617 | 0.120 |
Why?
|
| Immunophenotyping | 3 | 2021 | 1681 | 0.120 |
Why?
|
| DNA | 1 | 2022 | 2693 | 0.120 |
Why?
|
| Microglia | 1 | 2015 | 164 | 0.120 |
Why?
|
| Thrombocythemia, Essential | 1 | 2015 | 162 | 0.110 |
Why?
|
| Transcription Factor 4 | 1 | 2013 | 36 | 0.110 |
Why?
|
| Ataxins | 1 | 2013 | 91 | 0.110 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 46 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 362 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2018 | 1620 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 2013 | 331 | 0.110 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2012 | 9 | 0.110 |
Why?
|
| Fluorouracil | 2 | 2008 | 1944 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 580 | 0.110 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 17 | 0.110 |
Why?
|
| Polycythemia Vera | 1 | 2015 | 238 | 0.110 |
Why?
|
| Ataxin-1 | 1 | 2013 | 148 | 0.110 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 52 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2013 | 149 | 0.110 |
Why?
|
| Stem Cell Niche | 2 | 2023 | 94 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2014 | 614 | 0.100 |
Why?
|
| Base Sequence | 3 | 2013 | 4917 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 395 | 0.100 |
Why?
|
| CD48 Antigen | 1 | 2011 | 2 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2011 | 54 | 0.100 |
Why?
|
| Gene Expression | 3 | 2012 | 3570 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2012 | 234 | 0.100 |
Why?
|
| Female | 16 | 2020 | 141928 | 0.100 |
Why?
|
| Genotype | 2 | 2011 | 4109 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 223 | 0.100 |
Why?
|
| Transcriptome | 4 | 2023 | 1859 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 167 | 0.100 |
Why?
|
| Blood Cell Count | 1 | 2011 | 225 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2011 | 406 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2020 | 4804 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2012 | 392 | 0.100 |
Why?
|
| Age Factors | 2 | 2011 | 5377 | 0.100 |
Why?
|
| Mammals | 2 | 2023 | 361 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 997 | 0.100 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 122 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2015 | 941 | 0.100 |
Why?
|
| Germ Cells | 3 | 2022 | 335 | 0.100 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 176 | 0.090 |
Why?
|
| Binding Sites | 1 | 2015 | 2171 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2010 | 53 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2011 | 138 | 0.090 |
Why?
|
| Disease | 1 | 2012 | 165 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 610 | 0.090 |
Why?
|
| Intestines | 1 | 2015 | 686 | 0.090 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 156 | 0.090 |
Why?
|
| Radiation Chimera | 1 | 2010 | 30 | 0.090 |
Why?
|
| beta Catenin | 1 | 2014 | 688 | 0.090 |
Why?
|
| Male | 15 | 2020 | 123000 | 0.090 |
Why?
|
| Antigens | 1 | 2011 | 292 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 174 | 0.090 |
Why?
|
| Erythropoiesis | 1 | 2010 | 74 | 0.090 |
Why?
|
| Interferons | 1 | 2011 | 291 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 392 | 0.090 |
Why?
|
| Lymphocyte Subsets | 1 | 2009 | 137 | 0.090 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2009 | 9 | 0.090 |
Why?
|
| Skin | 1 | 2015 | 1259 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 7548 | 0.090 |
Why?
|
| Twist-Related Protein 1 | 1 | 2009 | 127 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 639 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 15193 | 0.080 |
Why?
|
| Rats | 2 | 2016 | 6086 | 0.080 |
Why?
|
| Lymphocyte Depletion | 1 | 2009 | 264 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 371 | 0.080 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2007 | 10 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 187 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2020 | 1113 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 650 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2007 | 2022 | 0.080 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2007 | 22 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 2796 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 974 | 0.080 |
Why?
|
| Immune System | 1 | 2009 | 279 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 139 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 834 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2011 | 1764 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2007 | 155 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 676 | 0.080 |
Why?
|
| Luciferases, Firefly | 1 | 2007 | 39 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 59 | 0.080 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2007 | 73 | 0.080 |
Why?
|
| Haplotypes | 1 | 2010 | 856 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2011 | 351 | 0.070 |
Why?
|
| P-Selectin | 1 | 2007 | 124 | 0.070 |
Why?
|
| Staining and Labeling | 2 | 2006 | 429 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2992 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 778 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 383 | 0.070 |
Why?
|
| Osteoblasts | 2 | 2011 | 370 | 0.070 |
Why?
|
| Endoglin | 1 | 2006 | 43 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 2483 | 0.070 |
Why?
|
| Integrases | 1 | 2007 | 262 | 0.070 |
Why?
|
| Retroviridae | 1 | 2006 | 332 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 337 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2007 | 512 | 0.070 |
Why?
|
| Receptor, TIE-2 | 1 | 2006 | 82 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2007 | 397 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2010 | 874 | 0.070 |
Why?
|
| Quality Control | 1 | 2007 | 457 | 0.070 |
Why?
|
| Teratoma | 1 | 2007 | 236 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2007 | 266 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1516 | 0.060 |
Why?
|
| Brain | 2 | 2022 | 4113 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 287 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 1129 | 0.060 |
Why?
|
| Aged | 4 | 2018 | 70117 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2007 | 798 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 241 | 0.060 |
Why?
|
| Parabiosis | 1 | 2004 | 14 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 987 | 0.060 |
Why?
|
| Autophagy | 1 | 2011 | 927 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1819 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 2007 | 359 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2007 | 749 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 241 | 0.060 |
Why?
|
| Anemia | 1 | 2010 | 689 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2005 | 87 | 0.060 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2004 | 72 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2014 | 1171 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.060 |
Why?
|
| Myosins | 1 | 2004 | 96 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 542 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 483 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2003 | 2 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 2527 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 238 | 0.060 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2003 | 38 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 6009 | 0.060 |
Why?
|
| Homozygote | 1 | 2005 | 717 | 0.060 |
Why?
|
| Neutropenia | 1 | 2007 | 968 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2003 | 264 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 210 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2004 | 220 | 0.060 |
Why?
|
| Complement Activation | 1 | 2003 | 94 | 0.060 |
Why?
|
| Electroporation | 1 | 2003 | 126 | 0.050 |
Why?
|
| Hybridomas | 1 | 2002 | 75 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2003 | 157 | 0.050 |
Why?
|
| Mammary Glands, Human | 1 | 2003 | 184 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 299 | 0.050 |
Why?
|
| Whole-Body Irradiation | 1 | 2003 | 307 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 21713 | 0.050 |
Why?
|
| Ikaros Transcription Factor | 1 | 2021 | 54 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 284 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 663 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 1029 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 769 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2004 | 829 | 0.050 |
Why?
|
| Anemia, Macrocytic | 1 | 2020 | 12 | 0.050 |
Why?
|
| Species Specificity | 1 | 2002 | 777 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1471 | 0.050 |
Why?
|
| Benchmarking | 1 | 2003 | 273 | 0.050 |
Why?
|
| Erythroid Cells | 1 | 2020 | 49 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2022 | 238 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2007 | 3001 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2007 | 1549 | 0.050 |
Why?
|
| Phenylenediamines | 1 | 2020 | 23 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 2307 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 1213 | 0.050 |
Why?
|
| Phosphopeptides | 1 | 2020 | 65 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2003 | 533 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 4367 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2004 | 1732 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2020 | 311 | 0.040 |
Why?
|
| Thymine DNA Glycosylase | 1 | 2019 | 6 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 1013 | 0.040 |
Why?
|
| Graft Survival | 1 | 2003 | 1062 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 182 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2020 | 119 | 0.040 |
Why?
|
| Heterografts | 1 | 2021 | 733 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 370 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 709 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 311 | 0.040 |
Why?
|
| Genes, myc | 1 | 2020 | 358 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 550 | 0.040 |
Why?
|
| Heart | 1 | 2005 | 1223 | 0.040 |
Why?
|
| Swine | 1 | 2002 | 1541 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2023 | 1046 | 0.040 |
Why?
|
| Reference Standards | 1 | 2018 | 339 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2009 | 2390 | 0.040 |
Why?
|
| Transfection | 1 | 2002 | 2944 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 2004 | 767 | 0.040 |
Why?
|
| Glutarates | 1 | 2016 | 44 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 1313 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 86204 | 0.040 |
Why?
|
| Granulocytes | 2 | 2007 | 224 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 508 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 2007 | 684 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 4971 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Muscles | 1 | 2015 | 416 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1763 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 2195 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 12 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 770 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 1053 | 0.030 |
Why?
|
| COS Cells | 1 | 2013 | 377 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 4758 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 810 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 265 | 0.030 |
Why?
|
| Glycosylation | 1 | 2013 | 213 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 518 | 0.030 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 83 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 469 | 0.030 |
Why?
|
| CD8 Antigens | 1 | 2012 | 170 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2012 | 170 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 644 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2012 | 185 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 679 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 2045 | 0.020 |
Why?
|
| Exome | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 703 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 286 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 3341 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 315 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 691 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 626 | 0.020 |
Why?
|
| CD5 Antigens | 1 | 2009 | 112 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2010 | 174 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 203 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2009 | 486 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 93 | 0.020 |
Why?
|
| Guided Tissue Regeneration | 1 | 2007 | 7 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 114 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 558 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 3518 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2011 | 629 | 0.020 |
Why?
|
| Platelet Count | 1 | 2007 | 490 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 577 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 3438 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2011 | 1450 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2007 | 593 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5178 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 503 | 0.020 |
Why?
|
| International Cooperation | 1 | 2007 | 323 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 866 | 0.020 |
Why?
|
| Presenilin-2 | 1 | 2004 | 20 | 0.020 |
Why?
|
| Research | 1 | 2007 | 415 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2004 | 44 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2004 | 71 | 0.020 |
Why?
|
| Mice, Inbred mdx | 1 | 2003 | 44 | 0.010 |
Why?
|
| Desmin | 1 | 2003 | 63 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2004 | 99 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 72 | 0.010 |
Why?
|
| Verapamil | 1 | 2003 | 78 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 77950 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2003 | 26 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 3569 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 182 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 135 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 2314 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2003 | 295 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 3890 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 597 | 0.010 |
Why?
|
| Endothelium | 1 | 2003 | 158 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 272 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 2927 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 229 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 198 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 3472 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 31252 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 1519 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1618 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 741 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 601 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 2218 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 891 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 1374 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 1304 | 0.010 |
Why?
|
| Wound Healing | 1 | 2003 | 815 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 21445 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 32848 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 2516 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 2403 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 7573 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 10035 | 0.000 |
Why?
|